SML Biopharm
Gwangmyeong
About SML Biopharm
SML Biopharm is a biotech company that develops next-generation cancer vaccines and therapeutics for cancer and various diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $3.0M
- Last round: Corporate Round (Dec 2023)
- Website: smlbiopharm.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sml-biopharm-67167 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.